515
report
Building Workforce Capacity to Improve Detection and Diagnosis of Dementia
The Alliance to Improve Dementia Care, part of the Milken Institute’s Center for the Future of Agin
g, utilizes
+ Read More
report
Giving Smarter: Philanthropic Opportunities to Advance Bipolar Disorder Research
People of all ages, ethnicities, and backgrounds endure the intense shifts in mood and energy level
s bipolar disorder (BD) causes.
+ Read More
report
Investing in America's Future: 2021 Policy Priorities and Solutions
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of s
ignificant policy concerns. Today, working together to solve those challenges is more imperative than ever.
+ Read More
report
Giving Smarter Guide: Lipedema
Lipedema is a chronic condition that occurs almost exclusively in women and manifests as symmetrica
l buildup of painful fat and swelling in the limbs, sparing the hands and feet.
+ Read More
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Global Opportunity Index 2022: White Paper
The Global Opportunity Index assesses countries' attractiveness to international investors using a
combination of economic, financial, institutional, and regulatory factors.
+ Read More
report
Global Opportunity Index 2022: Focus on Emerging Southeast Asia
This report uses the 2022 Global Opportunity Index (GOI) and its various categories to examine the
attractiveness of emerging Southeast Asia as a foreign investment destination—especially when compared to other emerging markets and developing economies
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Ghana’s Daakye Bond Program: An African Securitization Case Study
In Akan, the most widely spoken language in Ghana, daakye means future. It is an apt name, therefor
e, for the Daakye bond program, which invests in Ghana’s future leaders through securitizing future government tax flows.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
report
Framing the Issues: Digital Mental Health in Asia
More than a decade since the World Health Organization declared “no health without mental health,”
its message bears heeding more than ever.
+ Read More